Info

NanoSpine develops and markets biological therapies for the treatment of degenerative disc disease. During the past five years, NanoSpine's principals have had extensive experience with biological platforms in spine and with minimally invasive techniques. Building on this experience, the principals have developed and begun testing a unique method of incisionless disc replacement and fusion. Current spinal techniques are all invasive procedures with significant associated risks. The biological therapies on the market are few and the artificial disc replacement models are less than ideal. NanoSpine's know-how, patent portfolio, and skeletal tissue engineering methods has the potential to revolutionize the field of orthopaedics, musculoskeletal disorders, and spine.